glp-1 medications and alcohol Therapeutics Their Emerging Role in and Substance Use Disorders: An Endocrinology Primer GLP-1s Hold Promise as Treatment

For patients with BMI 35 kg/m (regardless of comorbidities) or BMI 30-34.9 kg/m with metabolic disease, bariatric surgery consultation may be appropriate, according to 2022 American Society for Metabolic and Bariatric Surgery guidelines

For example, a study from However, keep in mind that many of these studies received funding from pharmaceutical companies, including the manufacturers of various GLP-1 drugs

This is particularly concerning during the first few weeks on a new dose when the effect can be surprisingly strong

That was the moment I KNEW." "If you're thinking about getting professional treatments like Keravive or PRP but are scared of the cost, TRY THIS FIRST